Kuraray (3405) Q3 2026 earnings summary
Event summary combining transcript, slides, and related documents.
Q3 2026 earnings summary
12 Nov, 2025Executive summary
Net sales for the nine months ended September 30, 2025, decreased 3.5% year-over-year to ¥593,424 million, with operating income down 37.3% to ¥46,358 million and net income attributable to owners of the parent down 51.1% to ¥22,784 million, mainly due to inventory valuation differences and lower sales volume.
Global economic uncertainty, U.S. tariff policies, and weak overseas demand contributed to the challenging business environment.
Financial highlights
Gross profit fell from ¥207,570 million to ¥184,454 million year-over-year.
Net income per share dropped to ¥71.35 from ¥140.83 year-over-year.
Comprehensive income declined sharply to ¥9,103 million from ¥51,598 million year-over-year.
Equity ratio decreased to 56.3% as of September 30, 2025, from 59.2% at the end of 2024.
Total assets increased slightly to ¥1,294.0 billion.
Outlook and guidance
Full-year net sales forecast revised downward to ¥810,000 million, operating income to ¥60,000 million, and net income attributable to owners of the parent to ¥23,000 million, reflecting a 3.6% to 30.3% decrease from previous guidance.
Net income per share for the full year is projected at ¥74.66.
Dividend forecast remains unchanged, with annual dividend of ¥54 per share planned.
Assumptions include average exchange rates of ¥149/USD and ¥168/EUR.
Latest events from Kuraray
- FY2025 profit dropped on impairments, but FY2026 forecasts a strong rebound and higher dividends.3405
Q4 202610 Feb 2026 - SentryGlas® dominates structural glass with high performance and sustainability, driving global growth.3405
Investor Update19 Dec 2025 - Profits and sales fell in 1H FY2025, but portfolio restructuring and buybacks advanced.3405
Q2 20268 Aug 2025 - High-performance PVOH products and cell culture solutions drive robust global growth outlook.3405
Investor Day 202519 Jun 2025 - Profits and shareholder returns rose, with robust guidance despite lower sales forecast.3405
Q3 202513 Jun 2025 - Record interim results and upgraded outlook, with increased dividends and share buybacks.3405
Q2 202513 Jun 2025 - Sales up, profits down; full-year outlook steady, major share buyback planned.3405
Q1 20266 Jun 2025 - Record sales and operating income, but net income fell on extraordinary losses; profit recovery forecast.3405
Q4 20255 Jun 2025